Team
Leadership Team
Seulki Lee, PhD
CEO
Dr. Lee, founder, is an expert in drug and protein delivery. His research is focused on identifying novel targets critically involved in the origination of the disease. He invented NLY01 and, in collaboration with Dr. Ted Dawson’s team, at John’s Hopkins School of Medicine, proved its exceptional neuroprotective activity in animal models of Parkinson’s disease and Alzheimer’s disease, which led to founding of Neuraly. Dr. Lee was Associate Professor of Radiology and Radiological Science at Johns Hopkins School of Medicine.
Viktor Roschke, PhD
CSO and Head of R&D
Dr. Roschke, co-founder, is Chief Scientific Officer and Head of Research and Development. He has more than 20 years of experience in drug development as senior executive in pharmaceutical and biotech companies such as Human Genome Sciences, Cogenesys, and Teva Pharmaceuticals.
Scientific Advisors
Ted Dawson, MD, PhD
Scientific Co-Founder, Advisor
Warren Olanow, MD
Clinical Advisor
Han Seok Ko, PhD
Scientific Co-Founder, Advisor
Martin Pomper, MD, PhD
Scientific Co-Founder, Advisor
Karl Kieburtz, MD, MPH
Clinical Advisor
Team
Adam Bell, PhD
VP, Translational Medicine and Regulatory Affairs
Barbara Rempe, SHRM-CP
Human Resource Manager
Celia Baula, PMP, MBA
Senior Director, Program Management and Quality Systems
Don Ho, PhD
Director, Intellectual Property
Yumin Oh, PhD
Principal Scientist, Drug Discovery
Subbu Karanth, PhD
Director, Toxicology
Svetlana Sosnovtseva, MS
Senior Director, Assay Development
Yen Lin, PhD
VP, Technology Development and Manufacturing
Anna Nesterenko, CPA
Director, Accounting and Finance
Donara Abramyan, PhD
Principal Scientist, Assay Development
Jacob Kim, MBA, CPA
Accounting and Finance
Benjamin Gibson, MSc
Alliance Management
Irina Grineva. MS
Assay Development